Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Stilgenbauer

Showing results (131-140 of 466) with videos related to

Pageof 47
Sort By:
Neoplasia (New York, N.Y.)|February 21, 2026
Corrigendum to "U-RT1 - A new model for Richter transformation" [Neoplasia Volume 23, Issue 1, January 2021, Pages 140-148]Teresa Schmid, Julia Maier, Melanie Martin, et al.
Blood|October 11, 2014
Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?Peter Dreger, Johannes Schetelig, Niels Andersen, et al.
International Journal of Cancer|May 16, 2014
Loss of cooperativity of secreted CD40L and increased dose-response to IL4 on CLL cell viability correlates with enhanced activation of NF-kB and STAT6Nupur Bhattacharya, Michaela Reichenzeller, Maiwen Caudron-Herger, et al.
Frontiers in Oncology|March 8, 2021
Adjuvant Therapy of High-Risk (Stages IIC-IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-AnalysisKonstantinos Christofyllakis, Claudia Pföhler, Moritz Bewarder, et al.
British Journal of Haematology|May 28, 2011
Nurse-like cells show deregulated expression of genes involved in immunocompetenceNupur Bhattacharya, Susanne Diener, Irina S Idler, et al.
British Journal of Haematology|July 2, 2019
Spontaneous regression of a plasmablastic lymphoma with MYC rearrangementKrista Yordanova, Stephan Stilgenbauer, Rainer M Bohle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genesDirk L Kienle, Christian Korz, Beate Hosch, et al.
British Journal of Haematology|January 16, 2007
Reduced-intensity conditioning followed by T-cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapseMark Ringhoffer, Stephanie von Harsdorf, Michael Schmitt, et al.
Future Oncology (London, England)|July 11, 2015
The CLL12 trial protocol: a placebo-controlled double-blind Phase III study of ibrutinib in the treatment of early-stage chronic lymphocytic leukemia patients with risk of early disease progressionPetra Langerbeins, Jasmin Bahlo, Christina Rhein, et al.
International Journal of Cancer|May 9, 2022
Modeling the B-cell receptor signaling on single cell level reveals a stable network circuit topology between nonmalignant B cells and chronic lymphocytic leukemia cells and between untreated cells and cells treated with kinase inhibitorsChristine Wolf, Carsten Maus, Michael R O Persicke, et al.
Pageof 47

Showing results (131-140 of 466) with videos related to

Sort By:
Pageof 47
Neoplasia (New York, N.Y.)|February 21, 2026
Corrigendum to "U-RT1 - A new model for Richter transformation" [Neoplasia Volume 23, Issue 1, January 2021, Pages 140-148]Teresa Schmid, Julia Maier, Melanie Martin, et al.
Blood|October 11, 2014
Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?Peter Dreger, Johannes Schetelig, Niels Andersen, et al.
International Journal of Cancer|May 16, 2014
Loss of cooperativity of secreted CD40L and increased dose-response to IL4 on CLL cell viability correlates with enhanced activation of NF-kB and STAT6Nupur Bhattacharya, Michaela Reichenzeller, Maiwen Caudron-Herger, et al.
Frontiers in Oncology|March 8, 2021
Adjuvant Therapy of High-Risk (Stages IIC-IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-AnalysisKonstantinos Christofyllakis, Claudia Pföhler, Moritz Bewarder, et al.
British Journal of Haematology|May 28, 2011
Nurse-like cells show deregulated expression of genes involved in immunocompetenceNupur Bhattacharya, Susanne Diener, Irina S Idler, et al.
British Journal of Haematology|July 2, 2019
Spontaneous regression of a plasmablastic lymphoma with MYC rearrangementKrista Yordanova, Stephan Stilgenbauer, Rainer M Bohle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genesDirk L Kienle, Christian Korz, Beate Hosch, et al.
British Journal of Haematology|January 16, 2007
Reduced-intensity conditioning followed by T-cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapseMark Ringhoffer, Stephanie von Harsdorf, Michael Schmitt, et al.
Future Oncology (London, England)|July 11, 2015
The CLL12 trial protocol: a placebo-controlled double-blind Phase III study of ibrutinib in the treatment of early-stage chronic lymphocytic leukemia patients with risk of early disease progressionPetra Langerbeins, Jasmin Bahlo, Christina Rhein, et al.
International Journal of Cancer|May 9, 2022
Modeling the B-cell receptor signaling on single cell level reveals a stable network circuit topology between nonmalignant B cells and chronic lymphocytic leukemia cells and between untreated cells and cells treated with kinase inhibitorsChristine Wolf, Carsten Maus, Michael R O Persicke, et al.
Pageof 47